Discontinuation report AVANDAMET
Report ID | 8084 |
Drug Identification Number | 02248441 |
Brand name | AVANDAMET |
Common or Proper name | Rosiglitazone maleate and metformin hydrochloride tablet |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE ROSIGLITAZONE |
Strength(s) | 1000MG 4.00MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100s |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-04-20 |
Remaining supply date | 2018-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-04-26 | French | Compare |
v3 | 2017-04-26 | English | Compare |
v2 | 2017-04-25 | French | Compare |
v1 | 2017-04-25 | English | Compare |
Showing 1 to 4 of 4